Malvern, Australia

Neeranat Thienthong


 

Average Co-Inventor Count = 8.5

ph-index = 1


Company Filing History:


Years Active: 2012-2014

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Neeranat Thienthong: Innovator in Pharmaceutical Compounds

Introduction

Neeranat Thienthong is a notable inventor based in Malvern, Australia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating viral infections. With a total of 5 patents to his name, Thienthong's work is recognized for its potential impact on medical treatments.

Latest Patents

Thienthong's latest patents include innovative compounds that offer new methods for treating viral infections. One of his notable inventions is related to bicyclic pyrimidinones, which provides a compound of Formula I or a pharmaceutically acceptable derivative, salt, or prodrug thereof. This invention also outlines a method for the treatment or prophylaxis of viral infections by administering an effective amount of the compound. Additionally, he has developed imidazopyrimidines, which similarly provide a compound of formula (I) for treating viral infections, along with pharmaceutical compositions that incorporate these compounds.

Career Highlights

Neeranat Thienthong is currently associated with Avexa Limited, a company focused on developing innovative therapies. His work at Avexa has allowed him to explore and expand his research in pharmaceutical compounds, contributing to advancements in the treatment of viral infections.

Collaborations

Thienthong collaborates with notable colleagues, including Eric Dale Jones and David Ian Rhodes. Their combined expertise enhances the research and development efforts within their field.

Conclusion

Neeranat Thienthong's contributions to pharmaceutical innovations demonstrate his commitment to improving medical treatments for viral infections. His patents reflect a significant advancement in the field, showcasing the potential for new therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…